FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to gynecology, and is intended to predict the recurrence of endometrioid ovarian cysts after surgical treatment. Intraoperatively, the peritoneal fluid is collected. The method for enzyme-linked immunosorbent assay determines the concentration of vascular endothelial growth factor (VEGF). When VEGF is expressed at 125.6 pg/ml or more, the concentration of tumor necrosis factor alpha (TNFα) is additionally determined. With a TNFα value of 1.725 pg/ml or more, recurrence of endometrioid ovarian cysts is predicted.
EFFECT: invention improves the accuracy of predicting the recurrence of the endometrioid ovarian cyst after the performed surgical treatment.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINING RISK OF RECURRENCE OF ENDOMETRIOID OVARIAN CYSTS AFTER SURGICAL TREATMENT | 2023 |
|
RU2811890C1 |
| METHOD FOR PREDICTION OF RECURRENT PAIN SYNDROME AFTER SURGICAL TREATMENT OF OVARIAN ENDOMETRIOMAS | 2024 |
|
RU2838949C1 |
| METHOD FOR INTEGRATED TREATMENT OF EXTERNAL GENITAL ENDOMETRIOSIS | 2013 |
|
RU2541089C1 |
| METHOD FOR PREDICTION OF POSTOPERATIVE FERTILITY RECOVERY IN FEMALES WITH ENDOMETRIOSIS GENITALIS EXTERNA | 2013 |
|
RU2523556C1 |
| METHOD FOR DETERMINATION OF ENDOMETRIOID OVARIAN FORMATIONS TYPE | 2016 |
|
RU2625751C1 |
| METHOD FOR PREDICTION OF RECURRENT ENDOMETRIOID OVARIAN CYSTS | 2018 |
|
RU2694882C1 |
| METHOD FOR PERSONALISED TREATMENT OF OVARIAN ENDOMETRIOSIS IN WOMEN OF REPRODUCTIVE AGE BASED ON A POINT DIAGNOSTIC SYSTEM | 2021 |
|
RU2761982C1 |
| METHOD FOR PREDICTING THE RECURRENCE OF ENDOMETRIAL CYSTS AFTER SURGICAL TREATMENT BY MEANS OF IMMUNOHISTOCHEMICAL MARKERS | 2017 |
|
RU2681219C1 |
| PREIMPLANTATION PREPARATION TO ECF PATIENTS WITH ENDOMETRIAL HYPOPLASIA AND REDUCTION OF OVARIAN RESERVE AFTER OPERATED EXTERNAL GENITAL ENDOMETRIOSIS | 2015 |
|
RU2591086C1 |
| METHOD OF TREATING EXTERNAL GENITAL ENDOMETRIOSIS | 2019 |
|
RU2711658C1 |
